×
For best experience we recommend to activate Javascript in your browser.
Recombinant APP (Ponezumab Biosimilar) antibody
The Humanized Chimeric anti-APP (Ponezumab Biosimilar) antibody has been validated for not_set. It is suitable to detect APP (Ponezumab Biosimilar) in samples from Human.
Catalog No. ABIN7597918
$340.97
$401.14
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
1 mg ABIN7598391
100 μg ABIN7597918
1 mg ABIN7598391
100 μg ABIN7597918
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant APP (Ponezumab Biosimilar) antibody (ABIN7597918)
Target
APP (Ponezumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for APP (Ponezumab Biosimilar) antibodies
Humanized
Clonality
All clonalities for APP (Ponezumab Biosimilar) antibodies
Chimeric
Conjugate
All conjugates for APP (Ponezumab Biosimilar) antibodies
This APP (Ponezumab Biosimilar) antibody is un-conjugated
Grade
Research Grade
Product Details anti-APP (Ponezumab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Research Grade Ponezumab Biosimilar Antibody
Specificity
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50
Purification
Protein A or G purified from cell culture supernatant.
Purity
>95 % by SDS-PAGE.
Isotype
IgG2 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target Details for APP (Ponezumab Biosimilar)
(hide)
Target
APP (Ponezumab Biosimilar)
Alternative Name
Ponezumab Biosimilar
Target Type
Biosimilar
Background
AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50
UniProt
P05067
CAS-No
1178862-65-1
Recently viewed
(hide)
Chat with us , powered by LiveChat